These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1097 related articles for article (PubMed ID: 19010148)

  • 21. Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC).
    Pizzarelli F; David S; Sala P; Icardi A; Casani A
    Am J Kidney Dis; 2006 Jun; 47(6):1027-35. PubMed ID: 16731298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of chronic kidney disease after renal transplantation: is it different from nontransplant patients?
    Jiménez Alvaro S; Marcén R; Teruel JL; Fernández Rodríguez A; Pascual J; Galeano C; Villacorta J; Burgos FJ; Ortuño J
    Transplant Proc; 2009; 41(6):2409-11. PubMed ID: 19715935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.
    Okonko DO; Grzeslo A; Witkowski T; Mandal AK; Slater RM; Roughton M; Foldes G; Thum T; Majda J; Banasiak W; Missouris CG; Poole-Wilson PA; Anker SD; Ponikowski P
    J Am Coll Cardiol; 2008 Jan; 51(2):103-12. PubMed ID: 18191732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study of various factors that could have an impact on the treatment with erythropoietin of hemodialysis anemia].
    Fernández-Gallego J; Ramos B; Ruiz A; Contreras J; Alvarez Bustos G; López de Novales E
    Nefrologia; 2000; 20(2):164-70. PubMed ID: 10853198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anemia after renal transplantation: an underestimated problem.
    Ott U; Busch M; Steiner T; Wolf G
    Transplant Proc; 2008 Dec; 40(10):3481-4. PubMed ID: 19100418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Causes of anemia in renal transplant recipients.
    Karakuş S; Kanbay M; Köseoğlu HK; Colak T; Haberal M
    Transplant Proc; 2004; 36(1):164-5. PubMed ID: 15013334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anemia after kidney transplantation is not completely explained by reduced kidney function.
    Chadban SJ; Baines L; Polkinghorne K; Jefferys A; Dogra S; Kanganas C; Irish A; Eris J; Walker R
    Am J Kidney Dis; 2007 Feb; 49(2):301-9. PubMed ID: 17261433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous iron dextran treatment in predialysis patients with chronic renal failure.
    Dahdah K; Patrie JT; Bolton WK
    Am J Kidney Dis; 2000 Oct; 36(4):775-82. PubMed ID: 11007680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Managing anaemia in kidney transplant patients with chronic kidney disease].
    López Oliva MO; Del Castillo Caba D; Fernández Fresnedo G
    Nefrologia; 2009; 29 Suppl 1():25-30. PubMed ID: 19675658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin.
    Tagboto S; Cropper L; Mostafa S; Turner J; Bailey G; Pugh-Clarke K
    J Ren Care; 2008 Sep; 34(3):112-5. PubMed ID: 18786076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of erythropoietin in anemia after heart transplantation.
    Gleissner CA; Klingenberg R; Staritz P; Koch A; Ehlermann P; Wiggenhauser A; Dengler TJ
    Int J Cardiol; 2006 Oct; 112(3):341-7. PubMed ID: 16309765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Re-establishment of erythropoietin responsiveness in end-stage renal failure following renal transplantation.
    Jeffrey RF; Kendall RG; Prabhu P; Norfolk DR; Will EJ; Davison AM
    Clin Nephrol; 1995 Oct; 44(4):241-7. PubMed ID: 8575124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The interaction between heart failure and other heart diseases, renal failure, and anemia.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Helicobacter pylori does not contribute to iron deficiency in hemodialysis patients].
    López T; Almirall J; Calvet X; Quesada M; Sanfeliú I; Segura F; García M
    Nefrologia; 2006; 26(6):673-8. PubMed ID: 17227244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of iron deficiency anemia in orthopedic surgery with intravenous iron: efficacy and limits: a prospective study.
    Theusinger OM; Leyvraz PF; Schanz U; Seifert B; Spahn DR
    Anesthesiology; 2007 Dec; 107(6):923-7. PubMed ID: 18043060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anemia after renal transplantation].
    Montanaro D
    G Ital Nefrol; 2007; 24(1):13-22. PubMed ID: 17342689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of the current management of renal transplant recipients on the prevalence of anemia and related costs.
    Gentil MA; Cabello V; Perez-Valdivia M; Lopez-Mendoza M; Gonzalez-Roncero F; Muñoz J; Bernal G; Pereira P; Rodriguez-Algarra G
    Transplant Proc; 2005 Nov; 37(9):3823-4. PubMed ID: 16386551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence of anemia in patients with chronic kidney disease.
    McClellan W; Aronoff SL; Bolton WK; Hood S; Lorber DL; Tang KL; Tse TF; Wasserman B; Leiserowitz M
    Curr Med Res Opin; 2004 Sep; 20(9):1501-10. PubMed ID: 15383200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.